FITT Highway Products, Inc. (OTCBB:FHWY) saw its stocks jump Thursday, gaining 0.026 cents, or 32.5% to finish at 10.6 cents, after announcing new medical tests on one of its products. The closing price was still well below its 52-week high of 20 cents, set late last April. Volume for the stock Thursday was 411,400 shares.

The company announced today that one of its operating partners, F.I.T.T. Energy Products Inc., will begin a randomized, single-center, double-blind, crossover trial to evaluate the impact of the “F.I.T.T. Energy With Resveratrol” energy shot and two leading competitors on resting blood pressure.

The two-ounce “FITT Energy Shot” is doctor-formulated with some exciting ingredients designed to provide energy without the negative side effects associated with other energy beverages. Among other things, FITT incorporates L-Arginine and Arginine AKG (amino acids) in significant quantity to potentially positively affect blood pressure.

As well, L-Arginine is found in dairy, brown rice and nuts, essential for optimum growth, and regulation of protein metabolism. L-Arginine can make blood vessels wider as opposed to the narrowing effect of caffeine.

FITT Highway Products, Inc. is a brand management Company which is in the process of mitigating its debt in order to effectively pursue its business plan. The Company has entered into an Operating Agreement with F.I.T.T. Energy Products Inc. to perform a majority of its operating services, including among other things, selling, marketing, producing and distributing the “F.I.T.T. Energy Shot With Resveratrol.”